Page last updated: 2024-12-04

1,2,4-trichlorobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,2,4-Trichlorobenzene: A Versatile Tool in Research

1,2,4-trichlorobenzene (TCB) is an organic compound with the formula C6H3Cl3. It is a colorless liquid with a characteristic odor. Though it might not sound exciting, TCB plays a crucial role in several areas of scientific research. Let's delve into its importance:

**1. Solvent Properties:**

* **High boiling point:** TCB has a high boiling point (213 °C) compared to other common solvents like dichloromethane or chloroform. This allows it to be used at higher temperatures, making it suitable for reactions that require elevated temperatures.
* **Good solvent for organic compounds:** TCB is a good solvent for many organic compounds, including aromatic hydrocarbons, ketones, and esters. This makes it valuable in various organic reactions and extractions.
* **Low reactivity:** TCB is relatively unreactive, meaning it doesn't readily participate in reactions with other molecules. This makes it an ideal solvent for sensitive reactions where unwanted side reactions need to be minimized.

**2. Applications in Research:**

* **Spectroscopy:** TCB is often used as a solvent for spectroscopic techniques like NMR (Nuclear Magnetic Resonance) and UV-Vis (Ultraviolet-Visible Spectroscopy). Its properties allow for clear and distinct signals in the spectra, enabling accurate analysis of molecules.
* **Crystallization:** TCB is an excellent solvent for recrystallization of various organic compounds. Its good solubility at high temperatures and low solubility at low temperatures facilitate the formation of high-quality crystals for analysis and further experiments.
* **Chemical synthesis:** TCB is employed as a solvent or reagent in various chemical reactions, particularly in organic synthesis where its high boiling point and non-reactive nature are advantageous.
* **Materials science:** TCB finds applications in the synthesis and characterization of various materials, such as polymers and nanomaterials.

**3. Importance for Researchers:**

The versatility of 1,2,4-trichlorobenzene makes it a valuable tool for researchers across disciplines:

* **Chemists:** Use it for reactions, analysis, and purification of organic compounds.
* **Biochemists:** Employ it for studying protein structures and interactions.
* **Material scientists:** Utilize it in the synthesis and characterization of novel materials.
* **Environmental scientists:** Study its environmental fate and potential impact.

**4. Safety Concerns:**

It is important to note that TCB is a hazardous chemical. It is considered toxic, and its use requires proper safety precautions like handling in a fume hood, wearing gloves, and appropriate eye protection.

**In summary, 1,2,4-trichlorobenzene is a versatile and powerful tool for research, offering valuable properties for various applications. However, its use requires careful handling due to its potential toxicity.**

1,2,4-trichlorobenzene : A trichlorobenzene with chloro substituents at positions 1, 2 and 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID13
CHEMBL ID296348
CHEBI ID28222
SCHEMBL ID22730
MeSH IDM0055069

Synonyms (86)

Synonym
BIDD:ER0328
63697-18-7
1,2,4-trichlorbenzol
as-trichlorobenzene
1,2,5-trichlorobenzene
CHEBI:28222 ,
trichlorobenzol
1,2,4-trichlorobenzol
1,3,4-trichlorobenzene
benzene, 1,2,4-trichloro-
inchi=1/c6h3cl3/c7-4-1-2-5(8)6(9)3-4/h1-3
1,4-trichlorobenzene
1,4-trichlorobenzol
nsc-406697
unsym-trichlorobenzene
wln: gr bg dg
trojchlorobenzen
benzene,2,4-trichloro-
hostetex l-pec
nsc406697
NCGC00090833-01
hsdb 1105
ai3-07775
ccris 5945
brn 0956819
einecs 204-428-0
nsc 406697
trojchlorobenzen [polish]
1,2,4-tcb
120-82-1
124-TCB ,
trichlorobenzene a
C06594
1,2,4-trichlorobenzene
GHL.PD_MITSCHER_LEG0.137
NCGC00090833-02
1,2,4-trichlorobenzene, anhydrous, >=99%
CHEMBL296348
1,2,4-trichloro-benzene
MLS001050173
smr001216523
T0376
AKOS000120900
NCGC00090833-03
NCGC00090833-04
benzene, 1,2,4-trichloro-, radical ion(1-)
BMSE000841
dtxcid701965
NCGC00258863-01
cas-120-82-1
tox21_201311
tox21_300563
NCGC00254336-01
dtxsid0021965 ,
ec 204-428-0
05iq959m1n ,
unii-05iq959m1n
FT-0606243
FT-0606251
1,2,4-trichlorobenzene [hsdb]
1,2,4-trichlorobenzene [mi]
2,4-dichlorophenyl chloride
SCHEMBL22730
J-503791
hipochem gm
benzene,1,2,4-trichloro-,radical ion(1-)(9ci)
mfcd00000547
STL481897
1,2,4-trichlorobenzene, spectrophotometric grade
1,2,4-trichlorobenzene, certified reference material, tracecert(r)
F0001-0333
1,2,4-trichlorobenzene, reagentplus(r), >=99%
1,2,4-trichlorobenzene, pestanal(r), analytical standard
1,2,4-trichlorobenzene, for hplc, >=99%
1,2,4-trichlorobenzene, uv hplc spectroscopic, 99.5%
1,2,4-trichlorobenzene, for synthesis, 99%
1,2,4-trichlorobenzene 100 microg/ml in hexane
1,2,4-trichlorobenzene 10 microg/ml in cyclohexane
1,2,4-trichlorobenzene 5000 microg/ml in methanol
Q1876830
EN300-20533
AMY40773
1,2,4-triclorobenzene
1,2,4-trichlorobenzene-ul-14c
104810-41-5
Z104478594

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In view of the reversibility of this porphyrin induction noted in a companion study, and the absence of other indications of discernible toxicity, this increased urinary excretion of porphyrins is best considered more of a compound-specific physiologic effect rather than a toxic effect."( Subchronic toxicity study of 1,2,4-trichlorobenzene in the rat, rabbit and beagle dog.
Hefner, RE; Kociba, RJ; Leong, BK, 1981
)
0.55
" Consequently, the SASS may be recommended as a promising configuration alternative for the waste streams containing toxic compounds."( Reducing effect of aerobic selector on the toxicity of synthetic organic compounds in activated sludge process.
Alkan, U; Eleren, SC, 2009
)
0.35
" Toxic unit (TU) and additional index (AI) were introduced to determine the outcome in combined tests, and the coexistence of Cu, Cd, Cr(III) and p-chlorobenzene was antagonism, and the effect of Cu, Cd, Cr(III) and o-chlorobenzene, Cu and 1,2,4-trichlorobenzene were synergism."( Joint toxicity of heavy metals and chlorobenzenes to pyriformis Tetrahymena.
Li, X; Liu, P; Lu, Y; Luo, H; Zhang, C; Zhang, T, 2014
)
0.58

Bioavailability

ExcerptReferenceRelevance
" This was partly attributed to low bioavailability and microbial toxicity of the xenobiotics."( Toxicity of xenobiotics during sulfate, iron, and nitrate reduction in primary sewage sludge suspensions.
Elsgaard, L, 2010
)
0.36
" The sorption, dissipation, and bioavailability of chlorobenzenes (CBs) in soil were investigated."( Immobilization of chlorobenzenes in soil using wheat straw biochar.
Gu, C; Jiang, X; Kengara, FO; Song, Y; Wang, F; Yang, X, 2013
)
0.39

Dosage Studied

1,2,4-Trichlorobenzene (TCB) labeled with C-14 was given perorally to rats at a dosage of 50 mg/kg for excretion and distribution studies. The aim of this study was to develop a partition-controlled dosing system to maintain constant concentrations of benzo(a)pyrene, 1,2-dichlorOBenzene, and 1,3,5-trichlorophenyl methyl sulfones.

ExcerptRelevanceReference
"1,2,4-Trichlorobenzene (TCB) labeled with C-14 was given perorally to rats at a dosage of 50 mg/kg for excretion and distribution studies."( Excretion, distribution and metabolism of 1,2,4-trichlorobenzene in rats.
Adachi, T; Niimura, T; Sato, M; Tanaka, A; Tsuchiya, T; Yamaha, T, 1986
)
1.98
" Free 2,4,5- and 2,3,5-isomers of trichlorothiophenol amounted to 33% of the urinary metabolites in the po dosed rats and 28% in the iv dosed rats; free 2,4,5- and 2,3,5-TCP's amounted to 1% and 10%, respectively."( Comparative metabolism of 1,2,4-trichlorobenzene in the rat and rhesus monkey.
Cragg, S; Kaylor, WH; Kopfler, FC; Lingg, RD; Pyle, SM; Smith, CC; Wolfe, GF,
)
0.43
"2,3,5- and 2,4,5-trichlorophenyl methyl sulfides, 2,3,5- and 2,4,5-trichlorophenyl methyl sulfoxides, and 2,3,5- and 2,4,5-trichlorophenyl methyl sulfones (TCPSO2Mes) were detected in the urine of rats dosed with 1,2,4-trichlorobenzene (TCB)."( Role of 2,3,5-trichlorophenyl methyl sulfone, a metabolite of 1,2,4-trichlorobenzene, in the induction of hepatic microsomal drug-metabolizing enzymes by 1,2,4-trichlorobenzene in rats.
Kato, Y; Kimura, R; Sato, M; Yamada, S, 1993
)
0.71
" The results showed the seed germination rate and vigor index were decreased with increasing concentration of 1,2,4-TCB, showing a definite dose-response relationship, and the seedling growth and root length were inhibited, showing definite time-response and dose-response relationships."( [Toxic effects of 1,2,4-trichlorobenzene on rice seed germination and seedling growth].
Du, Q; Jia, X; Yuan, B, 2006
)
0.67
" The aim of this study was to develop a partition-controlled dosing system to maintain constant concentrations of benzo(a)pyrene, 1,2-dichlorobenzene, and 1,2,4-trichlorobenzene in an ethoxyresorufin-O-deethylase (EROD) assay and a cytotoxicity assay with the rainbow trout (Oncorhynchus mykiss) cell lines RTL-W1 and RTgill-W1."( Development of a partition-controlled dosing system for cell assays.
Busser, FJ; Escher, BI; Hermens, JL; Kramer, NI; Oosterwijk, MT; Schirmer, K, 2010
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trichlorobenzeneAny member of the class of chlorobenzenes carrying three chloro substituents at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
u03B3-hexachlorocyclohexane degradation620
1,2,4-trichlorobenzene degradation107

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency28.18380.000221.22318,912.5098AID588515
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency59.51780.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency61.13060.001022.650876.6163AID1224838
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency42.37710.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency11.63100.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency5.30450.001530.607315,848.9004AID1224841
pregnane X nuclear receptorHomo sapiens (human)Potency70.79460.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency53.04530.000229.305416,493.5996AID1259383
thyroid stimulating hormone receptorHomo sapiens (human)Potency2.98300.001628.015177.1139AID1224843
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency0.01580.316212.443531.6228AID924
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.00320.010039.53711,122.0200AID588545
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency30.63790.000323.4451159.6830AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency33.40190.000627.21521,122.0200AID651741; AID743219
Integrin beta-3Homo sapiens (human)Potency0.01580.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency0.01580.316211.415731.6228AID924
Nuclear receptor ROR-gammaHomo sapiens (human)Potency3.75780.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (83)

Processvia Protein(s)Taxonomy
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (32)

Processvia Protein(s)Taxonomy
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID162229Toxicity determined using Konemann's Industrial Pollutants Toxicity Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (116)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (18.97)18.7374
1990's17 (14.66)18.2507
2000's34 (29.31)29.6817
2010's37 (31.90)24.3611
2020's6 (5.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.05 (24.57)
Research Supply Index4.80 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index70.16 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.83%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other119 (99.17%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]